The 10.5% Vaccine Plus Reverse Convertible Bond is redeemed at 100% of the nominal value at the maturity date (September 2022), provided that the closing price of each of the two underlying shares (BioNTech und Moderna) quotes above the barrier of 50% of the respective strike at the end of the term (observation only at the final valuation date). The interest amount of 10.5% is paid out, regardless of the performance of the underlying shares.
In case at least one of the underlying shares quotes below its barrier (50%) at the final valuation date, the predefined amount of the worst performing share will be delivered.
Underlying Worst of Basket - basket members
1 to 2 from 2 results
Underlying prices are provided by FactSet. All data related to an underlying, such as e.g. stock prices, are at least 15 minutes delayed, depending on the stock exchange.
The price displayed for this underlying is solely an indication. It is not a price determined by the relevant entity (according to the Final Terms), but a real-time proxy. The price indication solely represents an approximate and non-binding information and, as far as the securities are concerned, is irrelevant for the determination of any payments as well as of any occurrence of specific events (depending on the security type, e.g., a barrier breach, an early redemption trigger, etc). The price indications are provided in cooperation with TTMzero GmbH. The indications are generally published from 8:00 to 22:00. The specified closing price does not correspond to the last price determined on the respective date by the relevant entity. Instead, it reflects the last indicative price of the day. Absolute and relative changes refer to the last indicative price of the preceding day and thus can deviate from the information specified by the relevant entity. In some cases, specific underlying events (e. g. a share split) are either not reflected in historical indicative prices or reflected there differently from the information specified by the relevant entity.
Content made available on this website and on its sub-sites (jointly, the “Site”) is provided for information purposes only (“Information”) and must not be considered as financial analysis or any other form of recommendation. The Information is not intended to be used as a substitute for investment advice. There is no obligation of Raiffeisen Centrobank AG (“RCB”) to keep the Information up-to-date.
Nothing contained herein should be considered as an offer or a solicitation of an offer to sell or to purchase any Securities issued by RCB (the “Securities”). The sole legal basis for any Securities issued by RCB is the respective published prospectus of the Structured Notes Programme of RCB which has been duly approved by the Austrian Financial Market Authority jointly with the applicable final terms, all of which are available for download on this website.
Public offers of securities which are based on a prospectus published on the following website are made by RCB exclusively to persons residing in one of the following member states: Republic of Austria, Republic of Croatia, Czech Republic, Federal Republic of Germany, Hungary, Italian Republic, Republic of Poland, Romania, Slovak Republic, and Republic of Slovenia (the “Offer Member States”). The respective product information for each of the Securities specifies in which of the Offer Member States the relevant issue of the Securities is publicly offered in accordance with the applicable rules at a given time; said data is available for download under the category “Public offer in” which can be accessed via www.rcb.at/en/investment-products/investment-products/overview/ or www.rcb.at/en/leverage-products/leverage-products/overview/. Persons who are not resident in such Offer Member State(s) are excluded from public offers of the Securities and are not targeted.
The Information is not addressed to persons residing in countries where distributing the Information would be illegal. Information, in whole or part, must not be retransmitted or distributed to persons from countries where such retransmission or distribution would be illegal, in particular to US nationals or to U.S. Persons (“U.S. Persons” within the meaning of Regulation S of the U.S. Securities Act of 1933, as amended, the “U.S. Securities Act”), as well as to Australian, Canadian, British or Japanese nationals or residents. Persons residing in these countries are not allowed to access this Site.
In particular, the Information provided on this Site is not assigned for persons residing in the USA and/or U.S. Persons. U.S. Persons and other U.S. residents are not allowed to access this Site. The Information provided on this Site may neither be distributed nor published in the USA, nor may any Securities, subject to certain exceptions, be sold or offered in the USA, to U.S. persons and/or to other U.S. residents. The Securities neither have been nor will be registered under the U.S. Securities Act, nor with any securities regulatory authority of any state or other jurisdiction of the USA, and are subject to U.S. tax law requirements. Trading in the Securities has not been approved for purposes of the U.S. Commodities Exchange Act of 1936. For this reason, the Securities may, inter alia, not be offered, sold or delivered within the United States or for the account and benefit of a U.S. person.
In spite of all due care given, RCB assumes no warranty nor does RCB make or give any representation as to the Information being reliable, accurate, complete, up to date, adequate or suitable for a specific purpose, nor that the access to the Site will be uninterrupted or error free. Past performance is not indicative of future results whatsoever. Trading with Securities involves financial risks and may even result in the partial or complete loss (total loss) of the invested capital.
The content on this Site is protected by trade mark, copyright and other intellectual property laws and is duly owned or used by RCB. Any reproduction or distribution of the Information in part or in whole is prohibited without RCB’s prior permission. RCB reserves the right to amend the terms set forth herein at any time. Amendments will be published on the Site. Users will be deemed to have accepted these amendments when continuing to use the Site.
CONFIRM: The user hereby explicitly confirms to consent to the terms set forth herein and of having been informed of all restrictions applicable to him/her. The user warrants that his/her access to this Site is neither restricted nor prohibited in accordance with the rules and laws applicable to him/her. The user further undertakes that he/she will not transmit or otherwise make available any Information contained in this Site to any person not being entitled to access this Site according to the applicable law.
CANCEL: The user hereby explicitly refuses to consent to the terms set forth herein.